Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04280653 · ClinicalTrials.gov registry record · NA
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
A NA study, sponsored by Mati Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04280653: Completed NA study, sponsored by Mati Therapeutics.
NCT04280653 is a NA study that has completed, run by Mati Therapeutics. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04280653, a NA study, has completed, sponsored by Mati Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
To evaluate the effect of the NDE L68 StableFit® punctal plug on the tear lake.
Primary Outcome
The primary study endpoint will be the comparison of the tear lake volume at baseline with the tear lake volume at each follow-up visit. The tear lake will be evaluated using a slit lamp micrometer, the micrometer will be oriented vertically and centered on the lower lid margin at the middle of the lower lid. The tear lake will be measured using the slit lamp micrometer from the lid margin to the superior border of the lower tear lake and measured to 0.1 mm. The average mean percent change from
Interventions
- DEVICE NDE L68 StableFit® Punctal Plug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-08-28 |
| Est. Completion | 2019-12-11 |
| Phase | NA |
What the finished NCT04280653 record still lists
NCT04280653 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which NDE L68 StableFit® Punctal Plug is the first listed.
NCT04280653 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04280653 about?
NCT04280653 is a clinical study titled "An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake". To evaluate the effect of the NDE L68 StableFit® punctal plug on the tear lake.
What is the current status of trial NCT04280653?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-08-28. Estimated completion is 2019-12-11.
What interventions are being tested in trial NCT04280653?
The interventions under investigation include: NDE L68 StableFit® Punctal Plug (DEVICE).
Who is sponsoring clinical trial NCT04280653?
This trial is sponsored by Mati Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04280653's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI